 |
|
Cultured Cells as a Screen for Novel Treatments of Alzheimer's Disease
Beth A. Malow, MD;
Andrea C. Baker;
John P. Blass, MD, PhD
Arch Neurol. 1989;46(11):1201-1203.
Abstract
• Two easily measured abnormal properties of fibroblasts from patients with Alzheimer's disease have been utilized to develop an in vitro test system for screening novel therapeutic agents for Alzheimer's disease. The abnormal properties selected for study were increased isoproterenol-stimulated cyclic adenosine monophosphate production and decreased pH (measured by the weak-acid distribution method). L-Carnitine was tested as a potential therapeutic agent, since it has been used to treat a variety of experimental metabolic encephalopathies. The addition of L-carnitine normalized both of these properties in the Alzheimer cells. Tissue culture may aid as a preliminary screen for identifying novel approaches to the treatment of Alzheimer's disease.
Author Affiliations
From the Altschul Laboratory for Dementia Research, Cornell University Medical College, Burke Rehabilitation Center, White Plains, NY. Dr Malow is presently with the Harvard-Longwood Neurology Training Program, Boston, Mass.
Footnotes
Accepted for publication March 13, 1989.
Reprint requests to Dementia Research Service, Burke Rehabilitation Center, 785 Mamaroneck Ave, White Plains, NY 10605 (Dr Blass).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Expression of 'Alzheimer Antigens' in Cultured Skin Fibroblasts
Blass et al.
Arch Neurol 1991;48:709-717.
ABSTRACT
Induction of Alzheimer Antigens by an Uncoupler of Oxidative Phosphorylation
Blass et al.
Arch Neurol 1990;47:864-869.
ABSTRACT
|
